US4215051A
(en)
|
1979-08-29 |
1980-07-29 |
Standard Oil Company (Indiana) |
Formation, purification and recovery of phthalic anhydride
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
EP0419569B1
(en)
|
1988-06-15 |
1995-09-06 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
US5137819A
(en)
|
1988-07-08 |
1992-08-11 |
University Of British Columbia |
Cellulose binding fusion proteins for immobilization and purification of polypeptides
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
EP0484440A4
(en)
|
1989-07-28 |
1993-01-07 |
Us Health |
Efficient directional genetic cloning system
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
DE69126668T2
(de)
|
1990-11-08 |
1997-10-23 |
Univ London |
Mycobacterium als adjuvans für antigene
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
JP3507486B2
(ja)
|
1991-03-15 |
2004-03-15 |
アムジエン・インコーポレーテツド |
顆粒球コロニー刺激因子の肺内投与
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
WO1993018147A1
(en)
|
1992-03-09 |
1993-09-16 |
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale |
Protein compound capable of inhibiting tumoral growth
|
WO1993021529A1
(en)
|
1992-04-14 |
1993-10-28 |
Duke University |
Method of detecting tumors containing complexes of p53 and hsp70
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
WO1994003599A1
(en)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
HUT73383A
(en)
|
1993-03-19 |
1996-07-29 |
Boehringer Sohn Ingelheim |
Process for preparing cancer vaccines
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
US5645829A
(en)
|
1993-06-18 |
1997-07-08 |
Beth Israel Hospital Association |
Mesothelial cell gene therapy
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
US5444087A
(en)
|
1993-10-19 |
1995-08-22 |
Bristol-Myers Squibb Company |
Manumycin compounds
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
CA2183667A1
(en)
|
1994-02-22 |
1995-08-24 |
Wayne A. Marasco |
Nucleic acid delivery system, method of synthesis and uses thereof
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
US5451569A
(en)
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
ES2125630T3
(es)
|
1994-07-08 |
1999-03-01 |
Baxter Int |
Dispositivo implantable que contiene celulas tumorales, para el tratamiento del cancer.
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
PT784483E
(pt)
|
1994-10-03 |
2001-05-31 |
Us Gov Health & Human Serv |
Composicao que compreende um virus recombinante que exprime um antigenio e um virus recombinante que exprime uma molecula imunoestimuladora
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
JP2000508884A
(ja)
|
1995-08-18 |
2000-07-18 |
スローンケタリング インスティテュート フォー キャンサー リサーチ |
癌および感染症の治療方法ならびにそれに有用な組成物
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
JPH11513369A
(ja)
|
1995-09-13 |
1999-11-16 |
フォーダム ユニバーシティー |
熱ショックタンパク質を用いる治療及び予防方法
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
JP2000516911A
(ja)
|
1996-03-28 |
2000-12-19 |
ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ |
オプソニン強化細胞、および抗原に対する免疫応答を調節する方法
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
DE69735376T2
(de)
|
1996-11-26 |
2006-12-14 |
Stressgen Biotechnologies Corp., Victoria |
Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
ATE362982T1
(de)
|
1997-01-28 |
2007-06-15 |
Human Genome Sciences Inc |
ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
US20040136951A1
(en)
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20050233958A1
(en)
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20080248046A1
(en)
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
US8101349B2
(en)
|
1997-12-23 |
2012-01-24 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells and their methods of use II
|
ES2285832T3
(es)
*
|
1998-02-20 |
2007-11-16 |
Univ Miami |
Complejo de peptido antigenico-proteina de choque termico modificada.
|
DE69940731D1
(de)
|
1998-05-26 |
2009-05-28 |
Genitrix Llc |
Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
US6335170B1
(en)
|
1999-02-22 |
2002-01-01 |
Torben F. Orntoft |
Gene expression in bladder tumors
|
US6317435B1
(en)
|
1999-03-08 |
2001-11-13 |
Qualcomm Incorporated |
Method and apparatus for maximizing the use of available capacity in a communication system
|
US7074403B1
(en)
|
1999-06-09 |
2006-07-11 |
Immunomedics, Inc. |
Immunotherapy of autoimmune disorders using antibodies which target B-cells
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
US8845861B2
(en)
|
2000-03-26 |
2014-09-30 |
Clariant Finance (Bvi) Limited |
Optical brightening compositions
|
WO2001078772A1
(en)
|
2000-04-17 |
2001-10-25 |
Mojave Therapeutics Inc. |
Heat shock protein-based antiviral vaccines
|
US7030219B2
(en)
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
DK1296711T3
(da)
|
2000-06-26 |
2006-08-28 |
Stressgen Biotechnologies Corp |
HPV-E7 til behandling af humant papillomavirus
|
DK1363938T3
(da)
|
2000-08-03 |
2014-03-24 |
Univ Johns Hopkins |
Molekylær vaccine, der forbinder et endoplasmisk reticulum-chaperonepolypeptid med et antigen
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
US20060062786A1
(en)
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20070292411A1
(en)
|
2000-11-08 |
2007-12-20 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
US20050214210A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20050214209A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
US7361341B2
(en)
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003005964A2
(en)
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
US20050019752A1
(en)
|
2001-11-16 |
2005-01-27 |
Genoveffa Franchini |
Novel chimeric rev, tat, and nef antigens
|
US7955845B2
(en)
|
2001-11-20 |
2011-06-07 |
Dana Farber Cancer Institute, Inc. |
Modified antigen-presenting cells
|
US20050214207A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind toTRAIL receptors
|
US20050214206A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20050214205A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20050214208A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
EP1539197A4
(en)
*
|
2002-02-01 |
2006-08-02 |
Univ Jefferson |
TREATMENT OF TUMOR CELLS FOR CANCER IMMUNOTHERAPY
|
WO2003072595A2
(en)
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
CA2483449A1
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
JP2005533015A
(ja)
|
2002-05-02 |
2005-11-04 |
ユニバーシティー オブ コネティカット ヘルス センター |
抗体療法の有効性を増強するための熱ショックタンパク質の使用
|
US20070298041A1
(en)
|
2002-06-28 |
2007-12-27 |
Tomlinson Ian M |
Ligands That Enhance Endogenous Compounds
|
AU2003259835A1
(en)
|
2002-08-15 |
2004-03-03 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
WO2004018698A2
(en)
|
2002-08-20 |
2004-03-04 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
US7629440B2
(en)
|
2002-08-20 |
2009-12-08 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
WO2004032865A2
(en)
|
2002-10-09 |
2004-04-22 |
Central Iowa Health System |
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
|
EP1578459A3
(en)
|
2002-10-25 |
2005-11-23 |
University of Connecticut Health Center |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
CN1764375A
(zh)
|
2003-02-20 |
2006-04-26 |
康涅狄格大学健康中心 |
使用包括热休克蛋白或α-2-巨球蛋白的组合物治疗癌症和传染病的方法
|
EP1601756B1
(en)
|
2003-02-20 |
2010-12-15 |
University of Connecticut Health Center |
Methods for the preparation of alpha (2) macroglobulin-antigenic molecule complexes
|
WO2004078921A2
(en)
|
2003-02-27 |
2004-09-16 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
AU2004268497A1
(en)
|
2003-02-28 |
2005-03-10 |
Antigenics Inc. |
Use of lectins to promote oligomerization of glycoproteins and antigenic molecules
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
EP1633316A4
(en)
|
2003-05-06 |
2008-04-02 |
Human Genome Sciences Inc |
ANTIBODIES BINDING IMMUNOSIPICALLY TO TRAIL RECEPTORS
|
KR100499278B1
(ko)
*
|
2003-07-05 |
2005-07-01 |
학교법인 포항공과대학교 |
로텍산 화합물이 공유결합된 고체 기판 및 이를 이용한바이오칩
|
EP2289547B1
(en)
|
2003-09-12 |
2015-12-16 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
AU2004275814A1
(en)
|
2003-09-26 |
2005-04-07 |
University Of Miami |
Tumor vaccine
|
US20070141666A1
(en)
|
2003-09-26 |
2007-06-21 |
Applied Research Systems Ars Holding N.V. |
Leader sequences for use in production of proteins
|
FR2867982B1
(fr)
*
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
MXPA06011805A
(es)
|
2004-04-16 |
2006-12-15 |
Genentech Inc |
Metodo para aumentar agotamiento de celulas b.
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
MX2007004176A
(es)
|
2004-10-06 |
2007-06-15 |
Mayo Foundation |
B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer.
|
CA2853335A1
(en)
|
2005-02-24 |
2006-11-23 |
Medical Research Council |
Hivcon: an hiv immunogen and uses thereof
|
WO2007030531A2
(en)
|
2005-09-06 |
2007-03-15 |
Molecular Image Inc. |
Reagents for testing and molecular imaging of liver cancer
|
CN101057975B
(zh)
|
2006-12-13 |
2012-10-10 |
中国科学院微生物研究所 |
一种抗免疫耐受性和免疫缺陷性病毒的鸡尾酒疫苗及其应用
|
AU2007339762B2
(en)
|
2006-12-27 |
2011-03-31 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
MX2010001194A
(es)
|
2007-07-31 |
2010-07-30 |
Univ Louisiana State |
Conjugado de polipeptido-acido nucleico para inmunoprofilaxis o inmunoterapia para desordenes neoplasicos o infecciones.
|
US20100080773A1
(en)
|
2008-09-26 |
2010-04-01 |
Sdg, Inc. |
Orally Bioavailable Lipid-Based Constructs
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
IL190438A0
(en)
|
2008-03-25 |
2008-12-29 |
K M B Y Ltd |
A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method
|
ATE541856T1
(de)
|
2008-04-02 |
2012-02-15 |
Sanofi Sa |
Stark verbrückte peptide aus der actinomadura namibiensis
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
US20110223196A1
(en)
|
2008-11-21 |
2011-09-15 |
University Of Miami |
Hiv/siv vaccines for the generation of mucosal and systemic immunity
|
UA109108C2
(uk)
|
2008-12-09 |
2015-07-27 |
Дженентек, Інк. |
Антитіло до pd-l1 та його застосування для посилення функції t-клітин
|
AU2010205782A1
(en)
|
2009-01-16 |
2011-09-08 |
Agirx Limited |
Vaccine compositions
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
EP2413953B1
(en)
|
2009-04-03 |
2017-11-08 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
US8993524B2
(en)
|
2010-03-05 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
US8865653B2
(en)
|
2010-04-22 |
2014-10-21 |
Institut Gustave Roussy |
Method of treatment for immunogenic treatment resistant cancer
|
WO2011131472A1
(en)
|
2010-04-22 |
2011-10-27 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
JP2013526582A
(ja)
|
2010-05-21 |
2013-06-24 |
ユニバーシティー オブ マイアミ |
癌治療
|
CA2828443A1
(en)
|
2011-02-23 |
2012-08-30 |
University Of Miami |
Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
|
US20140335050A1
(en)
|
2011-05-27 |
2014-11-13 |
The General Hospital Corporation |
Methods, compositions, and kits for the treatment of cancer
|
WO2014140884A2
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|
CA2906356A1
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Antibodies to mica and micb proteins
|